SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system
14 references·0 citing·32 second hop
Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system (2025)Incidence and window period residual risk…HIV incidence in US first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment (2025)HIV incidence in US first‐tim…Prevalence of Transfusion-Transmissible Infections Among Voluntary Blood Donors in a Tertiary Care Hospital (2024)Prevalence of Transfusion-Tra…International review of blood donation nucleic acid amplification testing (2024)International review of blood…Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID ‐19 pandemic (2024)Changes in transfusion‐transm…HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)HIV, HCV, and HBV incidence a…Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Screening Blood Donors for HI…Prevalence of human immunodeficiency virus , hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion‐Transmissible Infections Monitoring System ( TTIMS ) (2020)Prevalence of human immunodef…HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men (2020)HIV incidence in US first-tim…Blood Donor Test-Seeking Motivation and Prior HIV Testing Experiences in São Paulo, Brazil (2015)Blood Donor Test-Seeking Moti…Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)Hepatitis B virus testing by …The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi’an, China between 1999 and 2009 (2012)The prevalence and trends of …Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and re…Human immunodeficiency virus test‐seeking blood donors in a large blood bank in São Paulo, Brazil (2010)Human immunodeficiency virus …The Risk of Transfusion-Transmitted Viral Infections (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Undisclosed human immunodeficiency virus risk factors identified through a computer‐based questionnaire program among blood donors in B razil (2013)Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors at the National Blood Bank, Amman, Jordan (2020)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Risk factors for retrovirus and hepatitis virus infections in accepted blood donors (2014)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Blood banking in China (2002)Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China (2016)Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016 (2018)Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013–2017 (2020)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Civilian walking blood bank emergency preparedness plan (2021)Health and healthcare disparities among U.S. women and men at the intersection of sexual orientation and race/ethnicity: a nationally representative cross-sectional study (2017)HIV risk behavior profiles among men who have sex with men interested in donating blood: Findings from the Assessing Donor Variability and New Concepts in Eligibility study (2023)Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases (2023)Prevention of transfusion-transmitted infections (2019)An international review of the characteristics of viral nucleic acid‐amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT (2024)International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection (2024)How do we decide how representative our donors are for public health surveillance? (2022)Transfusion transmissible infections among blood donors in Ghana: A 3‐year multicentered health facility‐based retrospective study (2023)HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada (2021)
this work references cited by second hop

References

  • 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 2013Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?109 cited
  • 2020Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 201678 cited
  • 2021HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men52 cited
  • 2020Prevalence of human immunodeficiency virus , hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion‐Transmissible Infections Monitoring System ( TTIMS )44 cited
  • 2012The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi’an, China between 1999 and 200941 cited
  • 2010Human immunodeficiency virus test‐seeking blood donors in a large blood bank in São Paulo, Brazil39 cited
  • 2020HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men34 cited
  • 2024International review of blood donation nucleic acid amplification testing29 cited
  • 2024Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID ‐19 pandemic15 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2015Blood Donor Test-Seeking Motivation and Prior HIV Testing Experiences in São Paulo, Brazil12 cited
  • 2025HIV incidence in US first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment8 cited
  • 2024Prevalence of Transfusion-Transmissible Infections Among Voluntary Blood Donors in a Tertiary Care Hospital7 cited
  • Cited by

    No citing works inside the corpus for this window.